导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -2.77% | 657/1050 |
| 近一周 | -2.77% | 882/1104 |
| 近一月 | -5.63% | 828/1103 |
| 近一季 | -17.01% | 912/1092 |
| 近半年 | -11.94% | 831/1070 |
| 近一年 | 4.53% | 494/1018 |
| 近两年 | 84.89% | 277/926 |
| 近三年 | 12.69% | 577/834 |
| 成立以来 | 69.64% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.79% 209/1070 |
20.22% 384/1101 |
- - |
- - |
| 2025 | 53.30% 162/1065 |
2.95% 548/1014 |
2.88% 443/1038 |
44.46% 134/1050 |
0.18% 442/1065 |
| 2024 | -2.55% 647/1011 |
-8.00% 700/960 |
-3.40% 541/983 |
24.32% 22/991 |
-11.79% 948/1011 |
| 2023 | -22.04% 723/952 |
1.07% 571/880 |
-1.05% 243/895 |
-3.25% 219/915 |
-19.43% 914/952 |
| 2022 | -18.49% 278/867 |
-3.12% 17/773 |
-4.54% 756/806 |
-12.45% 427/845 |
0.67% 415/867 |
| 2021 | 21.46% 148/740 |
-10.09% 493/580 |
9.04% 386/659 |
20.00% 18/704 |
3.24% 291/740 |
| 2020 | 31.70% 341/554 |
-1.88% 212/419 |
14.46% 364/466 |
3.48% 381/517 |
13.33% 242/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 工银产业升级股票C VS. 东吴新产业精选股票A(580008) |